Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits?

Per Med. 2019 Sep;16(5):365-367. doi: 10.2217/pme-2019-0045. Epub 2019 Sep 25.

Kathryn A Phillips^{1

2}, Deborah A Marshall³, Allison W Kurian⁴

¹ UCSF Center for Translational & Policy Research on Personalized Medicine (TRANSPERS), Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA.
² UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA.
³ Department of Community Health Sciences, University of Calgary, Calgary, AB T2N 4Z6, Canada.
⁴ Departments of Medicine & of Health Research & Policy, Stanford University, Palo Alto, CA 94304, USA.

No abstract available

Keywords: economics; evidence-based medicine; precision medicine; preferences.

Publication types